Keystone, E

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

Emery, P., Keystone, E., Tony, H. P., Cantagrel, A., van Vollenhoven, R., Sanchez, A., Alecock, E., Lee, J., & Kremer, J. (2008) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research

Cited by 1,104

Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations

Aletaha, D., Landewe, R., Karonitsch, T., Bathon, J., Boers, M., Bombardier, C., Bombardieri, S., Choi, H., Combe, B., Dougados, M., et al. (2008) · Arthritis Care & Research

Rheumatoid Arthritis Research and TherapiesStatistical Methods in Clinical Trials

Cited by 214

Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes

Da Sylva, T. R., Connor, A., Mburu, Y., Keystone, E., & Wu, G. E. (2005) · Arthritis Research & Therapy

Rheumatoid Arthritis Research and TherapiesMitochondrial Function and Pathology

Cited by 73